Systemic effects of white adipose tissue dysregulation and obesity-related inflammation (Q37798716)

23 August 2017

Systemic effects of white adipose tissue dysregulation and obesity-related inflammation (English)

1 reference

23 August 2017

0 references

0 references

Josep Bassaganya-Riera

series ordinal

2

object named as

Josep Bassaganya-Riera

1 reference

23 August 2017

Amir J Guri

1

1 reference

23 August 2017

7 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

19

1 reference

23 August 2017

689-700

1 reference

23 August 2017

4

1 reference

Prevalence of overweight and obesity in the United States, 1999-2004

23 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The medical complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Annual medical spending attributable to obesity: payer-and service-specific estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Adipose tissue as a buffer for daily lipid flux

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Relationship between adipocyte size and adipokine expression and secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Should adipokines be considered in the choice of the treatment of obesity-related health problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

PKC-theta knockout mice are protected from fat-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Adipokines as regulators of muscle metabolism and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Peroxisome proliferator-activated receptor-gamma coactivator-1alpha overexpression increases lipid oxidation in myocytes from extremely obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Leptin receptor 170 kDa (OB-R170) protein expression is reduced in obese human skeletal muscle: a potential mechanism of leptin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Globular adiponectin stimulates glucose transport in type 2 diabetic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Contribution of leptin receptor N-linked glycans to leptin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Role of adiponectin in human skeletal muscle bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Resistin acutely impairs insulin-stimulated glucose transport in rodent muscle in the presence, but not absence, of palmitate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The expression of TNF alpha by human muscle. Relationship to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

IKK-beta links inflammation to obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Renal glucose production and utilization: new aspects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Fatty acids and insulin resistance in muscle and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Palmitate induces insulin resistance without significant intracellular triglyceride accumulation in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The protein kinase IKKepsilon regulates energy balance in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Critical role of Kupffer cells in the management of diet-induced diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Adipokines in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The role of the sympathetic nervous system in promoting liver cirrhosis induced by carbon tetrachloride, using the essential hypertensive animal (SHR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Inhibition of rat liver fibrogenesis through noradrenergic antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Role of adipocytokines in hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Serum chemerin and vaspin in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Chemerin reveals its chimeric nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Synthetic chemerin-derived peptides suppress inflammation through ChemR23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Retinol-binding protein 4 in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: a three year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Beta-cell failure as a complication of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Islet beta cell failure in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Mechanisms linking obesity to insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Long-term exposure of beta-INS cells to high glucose concentrations increases anaplerosis, lipogenesis, and lipogenic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Induction by glucose of genes coding for glycolytic enzymes in a pancreatic beta-cell line (INS-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Inhibition of insulin gene expression by long-term exposure of pancreatic beta cells to palmitate is dependent on the presence of a stimulatory glucose concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Differential effects of hyperlipidemia on insulin secretion in islets of langerhans from hyperglycemic versus normoglycemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Glucolipotoxicity: fuel excess and beta-cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for 1 wk in high glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Overstimulation and beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Functional and molecular defects of pancreatic islets in human type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Increasing triglyceride synthesis inhibits glucose-induced insulin secretion in isolated rat islets of langerhans: a study using adenoviral expression of diacylglycerol acyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Macrophages, cytokines and beta-cell death in Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Increased number of islet-associated macrophages in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Islet-associated macrophages in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Obesity, proteinuria and progression of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Cellular lipid metabolism and the role of lipids in progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Obesity and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Plasminogen activator inhibitor-1 and diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Glucose Down-regulates the Expression of the Peroxisome Proliferator-activated Receptor-α Gene in the Pancreatic β-Cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Regulation of fat metabolism in skeletal muscle.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Leptin enhances TNF-alpha production via p38 and JNK MAPK in LPS-stimulated Kupffer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

An ELISA for plasma retinol-binding protein using monoclonal and polyclonal antibodies: plasma variation in normal and insulin resistant subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Overweight, obesity and chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Nephrin Is Critical for the Action of Insulin on Human Glomerular Podocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

The Role of the TGF/Smad Signaling Pathway in Peritoneal Fibrosis Induced by Peritoneal Dialysis Solutions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Cellular events in the evolution of experimental diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fears

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

7 January 2021

Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

7 January 2021

Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

7 January 2021

Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.230

7 January 2021

Identifiers

DOI

10.1038/OBY.2010.230

1 reference

23 August 2017

1 reference

PubMed ID

20930712